Treatment

Clinical Trials Treatment

New Large Study Analyzed Inherited EGFR T790M Mutation and Lung Cancer Risk

Inherited genetic factors can contribute to EGFR lung cancer risk, but the role of rare…

Irene Guijarro MunozSeptember 29, 2026

Clinical Trials Treatment

BioNTech BNT116 Cancer Vaccine Shows Promising Early Activity in Resectable NSCLC

A new Phase I study, 53% of patients with available tissue had a major pathological…

Irene Guijarro MunozSeptember 24, 2026

Treatment

Moderna’s Personalized mRNA Cancer Vaccine Programs in NSCLC

Learn how mRNA cancer vaccines like Moderna's V940 and mRNA-4359 are being studied in NSCLC…

Irene Guijarro MunozSeptember 3, 2026

Biomarker Testing Treatment

ctDNA and Liquid Biopsy in RET-Positive Lung Cancer

A simple blood draw can now reveal what's happening inside a tumor — no surgery…

Irene Guijarro MunozAugust 12, 2026

RET inhibitor and chemotherapy treatment for lung cancer

Research Treatment

Continuing a RET Inhibitor With Chemotherapy After Progression May Improve Outcomes For RET Lung Cancer Patients

RET Inhibitor with chemotherapy after progression may improve outcomes for RET lung cancer patients

Irene Guijarro MunozJuly 10, 2026

Clinical Trials Research Treatment

BioNTech’s BNT116 mRNA cancer vaccine trial currently open at MD Anderson and Johns Hopkins

Exciting news for the RET community! BioNTech’s BNT116 mRNA cancer vaccine trial now enables combination…

Irene Guijarro MunozApril 27, 2026

Clinical Trials Treatment

Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Eli Lilly and Company announced positive results from the Phase 3 LIBRETTO-432 clinical trial evaluating…

Irene Guijarro MunozFebruary 17, 2026

Education Treatment

Finding the Right RET Oncologist for Your Cancer Treatment

Finding the right oncologist and medical care team is one of the most important decisions…

Irene Guijarro MunozFebruary 13, 2026

Research Treatment

2025 IASLC Targeted Therapies Recap

#TogetherSeparately: live virtual meetup to summarize data presented in February’s IASLC Targeted Therapies Meeting. March…

Irene Guijarro MunozMarch 20, 2025

cancer cells, ret gene, ret rearrangements, ret fusion, most successful cancer treatment

Education Treatment

Breaking Ground: The Most Successful Treatment Options for RET-Positive Lung Cancer

Discover the most effective RET cancer treatment options available today, their benefits, and what to…

Irene Guijarro MunozJanuary 27, 2025

New Large Study Analyzed Inherited EGFR T790M Mutation and Lung Cancer Risk

BioNTech BNT116 Cancer Vaccine Shows Promising Early Activity in Resectable NSCLC

Moderna’s Personalized mRNA Cancer Vaccine Programs in NSCLC

ctDNA and Liquid Biopsy in RET-Positive Lung Cancer

Continuing a RET Inhibitor With Chemotherapy After Progression May Improve Outcomes For RET Lung Cancer Patients

BioNTech’s BNT116 mRNA cancer vaccine trial currently open at MD Anderson and Johns Hopkins

Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Finding the Right RET Oncologist for Your Cancer Treatment

2025 IASLC Targeted Therapies Recap

Breaking Ground: The Most Successful Treatment Options for RET-Positive Lung Cancer

Popular Posts

Scientific research can be confusing and overwhelming